A First in human study of PI-2620 evaluating tau in AD and other tauopathies
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2017
At a glance
- Drugs PI 2620 (Primary)
- Indications Alzheimer's disease; Tauopathies
- Focus Diagnostic use; First in man
- 03 Apr 2017 First results from this trial were presented at the International conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD), according to a Piramal Imaging media release.
- 03 Apr 2017 Results published in a Piramal Imaging media release.
- 30 Mar 2017 New trial record